<DOC>
	<DOCNO>NCT02688062</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety NeuroRegen Scaffold bone marrow mononuclear cell ( BMMCs ) neurological recovery follow chronic complete spinal cord injury , compare treatment surgical intradural decompression adhesiolysis .</brief_summary>
	<brief_title>NeuroRegen Scaffoldâ„¢ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression Adhesiolysis SCI</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>1 . Completely spinal cord injury thoracic level assess magnetic resonance imaging ( MRI ) electrophysiology . 2 . ASIA Impairment Scale ( AIS ) grade A . 3 . Male female , 1860 year old . 4 . No significant improvement injury rehabilitation . 5 . Patients normal peripheral nerve function without muscle atrophy . 6 . Cardiovascular , respiratory , liver , kidney function laboratory examination within normal range . 7 . No brain disease mental disorder . 8 . Ability willingness regular visit hospital follow protocol procedure . 9 . Patients sign informed consent . 1 . A current diagnosis primary disease affect limb function ( e.g. , traumatic brain injury , cerebral hemorrhage , cognitive disorder central nervous system disease ) . 2 . Patients without rehabilitation train injury . 3 . Remarkable muscle atrophy fibrosis . 4 . Degeneration peripheral nerve function . 5 . Allergic constitution . 6 . Participation immunomodulator therapy experimental drug treatment within 60 day prior study . 7 . Suffering diabetes , autoimmune disease , tumor severe hypertension . 8 . Patients severe heart , lung , liver renal dysfunction unable meet surgery standard . 9 . Severe bleeding tendency abnormal coagulation function . 10 . Inflammation skin ulcer surgical site . 11 . Lactating pregnant woman . 12 . Poor compliance , difficult complete study . 13 . Any condition might increase risk subject interfere clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>